Form 8-K - Current report:
SEC Accession No. 0001104659-25-030870
Filing Date
2025-04-02
Accepted
2025-04-02 06:29:14
Documents
70
Period of Report
2025-04-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510984d1_8k.htm   iXBRL 8-K 35764
2 EXHIBIT 1.1 tm2510984d1_ex1-1.htm EX-1.1 230874
3 EXHIBIT 5.1 tm2510984d1_ex5-1.htm EX-5.1 11285
4 EXHIBIT 99.1 tm2510984d1_ex99-1.htm EX-99.1 10822
5 EXHIBIT 99.2 tm2510984d1_ex99-2.htm EX-99.2 80003
9 GRAPHIC tm25109841_ex5-1img001.jpg GRAPHIC 3969
10 GRAPHIC tm25109841_ex5-1img002.jpg GRAPHIC 2164
11 GRAPHIC tm2510984d1_ex99-1img001.jpg GRAPHIC 18194
12 GRAPHIC tm2510984d1_ex99-2img001.jpg GRAPHIC 66562
13 GRAPHIC tm2510984d1_ex99-2img002.jpg GRAPHIC 331339
14 GRAPHIC tm2510984d1_ex99-2img003.jpg GRAPHIC 131804
15 GRAPHIC tm2510984d1_ex99-2img004.jpg GRAPHIC 148656
16 GRAPHIC tm2510984d1_ex99-2img005.jpg GRAPHIC 86702
17 GRAPHIC tm2510984d1_ex99-2img006.jpg GRAPHIC 168811
18 GRAPHIC tm2510984d1_ex99-2img007.jpg GRAPHIC 90461
19 GRAPHIC tm2510984d1_ex99-2img008.jpg GRAPHIC 116658
20 GRAPHIC tm2510984d1_ex99-2img009.jpg GRAPHIC 163096
21 GRAPHIC tm2510984d1_ex99-2img010.jpg GRAPHIC 148616
22 GRAPHIC tm2510984d1_ex99-2img011.jpg GRAPHIC 103092
23 GRAPHIC tm2510984d1_ex99-2img012.jpg GRAPHIC 146198
24 GRAPHIC tm2510984d1_ex99-2img013.jpg GRAPHIC 113279
25 GRAPHIC tm2510984d1_ex99-2img014.jpg GRAPHIC 185982
26 GRAPHIC tm2510984d1_ex99-2img015.jpg GRAPHIC 129725
27 GRAPHIC tm2510984d1_ex99-2img016.jpg GRAPHIC 116434
28 GRAPHIC tm2510984d1_ex99-2img017.jpg GRAPHIC 108474
29 GRAPHIC tm2510984d1_ex99-2img018.jpg GRAPHIC 51185
30 GRAPHIC tm2510984d1_ex99-2img019.jpg GRAPHIC 139371
31 GRAPHIC tm2510984d1_ex99-2img020.jpg GRAPHIC 179314
32 GRAPHIC tm2510984d1_ex99-2img021.jpg GRAPHIC 186287
33 GRAPHIC tm2510984d1_ex99-2img022.jpg GRAPHIC 154480
34 GRAPHIC tm2510984d1_ex99-2img023.jpg GRAPHIC 125168
35 GRAPHIC tm2510984d1_ex99-2img024.jpg GRAPHIC 159964
36 GRAPHIC tm2510984d1_ex99-2img025.jpg GRAPHIC 229348
37 GRAPHIC tm2510984d1_ex99-2img026.jpg GRAPHIC 166832
38 GRAPHIC tm2510984d1_ex99-2img027.jpg GRAPHIC 113619
39 GRAPHIC tm2510984d1_ex99-2img028.jpg GRAPHIC 156793
40 GRAPHIC tm2510984d1_ex99-2img029.jpg GRAPHIC 52945
41 GRAPHIC tm2510984d1_ex99-2img030.jpg GRAPHIC 126186
42 GRAPHIC tm2510984d1_ex99-2img031.jpg GRAPHIC 99865
43 GRAPHIC tm2510984d1_ex99-2img032.jpg GRAPHIC 113036
44 GRAPHIC tm2510984d1_ex99-2img033.jpg GRAPHIC 156002
45 GRAPHIC tm2510984d1_ex99-2img034.jpg GRAPHIC 30021
46 GRAPHIC tm2510984d1_ex99-2img035.jpg GRAPHIC 148826
47 GRAPHIC tm2510984d1_ex99-2img036.jpg GRAPHIC 177971
48 GRAPHIC tm2510984d1_ex99-2img037.jpg GRAPHIC 256162
49 GRAPHIC tm2510984d1_ex99-2img038.jpg GRAPHIC 133077
50 GRAPHIC tm2510984d1_ex99-2img039.jpg GRAPHIC 71858
51 GRAPHIC tm2510984d1_ex99-2img040.jpg GRAPHIC 125718
52 GRAPHIC tm2510984d1_ex99-2img041.jpg GRAPHIC 135718
53 GRAPHIC tm2510984d1_ex99-2img042.jpg GRAPHIC 115344
54 GRAPHIC tm2510984d1_ex99-2img043.jpg GRAPHIC 179553
55 GRAPHIC tm2510984d1_ex99-2img044.jpg GRAPHIC 166205
56 GRAPHIC tm2510984d1_ex99-2img045.jpg GRAPHIC 174328
57 GRAPHIC tm2510984d1_ex99-2img046.jpg GRAPHIC 137885
58 GRAPHIC tm2510984d1_ex99-2img047.jpg GRAPHIC 191031
59 GRAPHIC tm2510984d1_ex99-2img048.jpg GRAPHIC 136799
60 GRAPHIC tm2510984d1_ex99-2img049.jpg GRAPHIC 202868
61 GRAPHIC tm2510984d1_ex99-2img050.jpg GRAPHIC 68148
  Complete submission text file 0001104659-25-030870.txt   10279330

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ewtx-20250402.xsd EX-101.SCH 3020
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewtx-20250402_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewtx-20250402_pre.xml EX-101.PRE 22362
72 EXTRACTED XBRL INSTANCE DOCUMENT tm2510984d1_8k_htm.xml XML 3567
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 25801976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)